Curly Morris
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 30
- Multiple Myeloma Research and Treatments 29
- Hematopoietic Stem Cell Transplantation 9
-
- Protein Degradation and Inhibitors 10
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
- Cancer therapeutics and mechanisms 3
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Mary Drake (8 shared papers)Jamie Cavenagh (7 shared papers)Heather Oakervee (3 shared papers)Rakesh Popat (3 shared papers)Dixie‐Lee Esseltine (3 shared papers)Nicola Curry (3 shared papers)Samir Agrawal (2 shared papers)David P. Schenkein (2 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Pathology (6 papers)British Journal of Haematology (5 papers)Bone Marrow Transplantation (4 papers)Biology of Blood and Marrow Transplantation (4 papers)
- Partner nations
- United KingdomSwedenGermany
In The Last Decade
Curly Morris
43 papers receiving 995 citations
Peers
Comparison fields: 5 of 80
- Hematology 764
- Oncology 345
- Genetics 91
- Molecular Biology 508
- Internal Medicine 12
Countries citing papers authored by Curly Morris
This map shows the geographic impact of Curly Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curly Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curly Morris more than expected).
Fields of papers citing papers by Curly Morris
This network shows the impact of papers produced by Curly Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curly Morris. The network helps show where Curly Morris may publish in the future.
Co-authors
The 25 scholars most cited alongside Curly Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 234 | |
| 2 | 2011 | 120 | |
| 3 | 2008 | 101 | |
| 4 | 2014 | 71 | |
| 5 | 1994 | 47 | |
| 6 | 2006 | 43 | |
| 7 | 2009 | 43 | |
| 8 | 2010 | 39 | |
| 9 | 2004 | 34 | |
| 10 | 2013 | 31 | |
| 11 | 2005 | 29 | |
| 12 | 1990 | 23 | |
| 13 | 1965 | 17 | |
| 14 | 2009 | 15 | |
| 15 | 2015 | 15 | |
| 16 | 2016 | 14 | |
| 17 | 1979 | 14 | |
| 18 | 2017 | 13 | |
| 19 | 1997 | 13 | |
| 20 | 2011 | 11 |
About Curly Morris
Curly Morris is a scholar working on Hematology, Molecular Biology, Oncology, Infectious Diseases and Pathology and Forensic Medicine, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (29 papers), Protein Degradation and Inhibitors (10 papers), Hematopoietic Stem Cell Transplantation (9 papers), Cancer Treatment and Pharmacology (6 papers), Peptidase Inhibition and Analysis (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Cancer therapeutics and mechanisms (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Hematology (764 citations), Oncology (345 citations), Genetics (91 citations), Molecular Biology (508 citations) and Internal Medicine (12 citations). Curly Morris has collaborated with scholars based in United Kingdom, Sweden and Germany. Frequent co-authors include Mary Drake, Jamie Cavenagh, Heather Oakervee, Rakesh Popat, Dixie‐Lee Esseltine, Nicola Curry, Samir Agrawal, David P. Schenkein, Gösta Gahrton and P C Sharpe. Their work appears in journals such as Blood, Journal of Clinical Pathology, British Journal of Haematology, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.